Transfusion medicine and patient safety [electronic resource] /
Series: Patient safety ; v. 7.Publication details: Berlin ; Boston : De Gruyter, c2013.Description: 1 online resourceISBN:- 9783110287073 (electronic bk.)
- 3110287072 (electronic bk.)
- WB 356
Item type | Home library | Class number | URL | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Electronic book | Stenhouse Library | Link to resource | Available |
Includes bibliographical references and index.
Introduction; 1 Basics of transfusion medicine; 1.1 The ABO and Rh blood group systems; 1.2 Other blood group systems; 1.2.1 The MNSs system; 1.2.2 The P system; 1.2.3 The Lutheran system; 1.2.4 The Kell system; 1.2.5 The Lewis system; 1.2.6 The Duffy system; 1.2.7 The Kidd system; 1.2.8 The Diego system; 1.2.9 The Xg-a system; 1.2.10 The Dombrock system; 1.2.11 The Colton system; 1.2.12 The Chido/Rodgers system; 1.2.13 The Cromer system; 1.2.14 The I/i system; 1.3 Natural and immune antibodies; 1.4 Transfusion guidelines; 1.4.1 Indications for the transfusion of concentrated red blood cells
1.4.2 Indications for the transfusion of platelet concentrates1.4.3 Indications for the transfusion of fresh frozen plasma; 1.4.4 Indications for the transfusion of leukodepleted blood components; 1.4.5 Indications for the transfusion of irradiated blood components; 1.4.6 Indications for granulocyte transfusions; 1.4.7 Virus-inactivated blood components; 1.4.8 Complications of transfusion therapy; 2 The transfusion process; 2.1 Blood donation; 2.2 Donating multiple blood components; 2.3 Preparation of blood and blood components; 2.4 The immunohematology laboratory
2.5 The immunohematology laboratory2.5.1 Studying the Rh system; 2.5.2 Detecting allo-antibodies to red cell antigens; 2.6 Transfusion request forms and the administration of blood and blood components; 3 Automation and computerization of the transfusion process; 3.1 Automation as a safety factor; 3.2 Computerization of the transfusion process: from donor to patient; 3.3 The computerized transfusion network; 3.4 Hemovigilance; 3.5 What can be improved in the future?; 4 Biological validation of blood components; 4.1 Molecular and serological methods; 4.1.1 Serological investigations
4.1.2 Molecular investigations4.1.3 Structure of the DNA; 4.1.4 Real-time PCR; 4.1.5 PCR-TMA; 4.2 Decision-making and the quality system; 4.3 Risk management versus patient safety: medicolegal considerations; 5 Error in transfusion medicine; Index
Description based on print version record.
There are no comments on this title.